2026 M. John Chapman: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	106	6359	5981	183	173	355	74030

Overview

M. John Chapman is affiliated with Inserm in France, contributing to the field of medicine with a primary focus on neurology and critical care. Their research spans multiple subfields including neurology, epidemiology, critical care and intensive care medicine, immunology and allergy, and anesthesiology and pain medicine. Chapman's work addresses clinical challenges and outcomes in acute and critical medical conditions.

The scientist's publication record highlights key research topics such as acute ischemic stroke management, traumatic brain injury and neurovascular disturbances, intensive care unit cognitive disorders, anesthesia and sedative agents, food allergy and anaphylaxis research, drug-induced adverse reactions, and the long-term effects of COVID-19.

Chapman has published extensively in several reputable medical journals. Frequent publication venues include the Canadian Medical Association Journal and Critical Care Medicine, each with two publications, as well as Stroke, the Journal of Neurotrauma, and the New England Journal of Medicine.

Selected recent papers include:

"Protected Code Stroke," 2020, published in Stroke
"Patient Outcomes at Twelve Months after Early Decompressive Craniectomy for Diffuse Traumatic Brain Injury in the Randomized DECRA Clinical Trial," 2020, Journal of Neurotrauma
"Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage," 2024, New England Journal of Medicine
"Effect of inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review and meta-analysis," 2023, British Journal of Anaesthesia
"Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review," 2024, Critical Care Explorations

Frequent collaborators in Chapman's research include Marat Slessarev, Damon C. Scales, Angela Jerath, Brian H. Cuthbertson, and Claudio M. Martin, each contributing to multiple joint publications.

Best Publications

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

7143
Citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

4084
Citations
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

3371
Citations
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆

Alberico L. Catapano;Zeljko Reiner;Guy De Backer;Ian Graham

3245
Citations
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

3072
Citations
Lipoprotein(a) as a cardiovascular risk factor: current status

Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén

2094
Citations
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti

1560
Citations
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

1484
Citations
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

1470
Citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

1283
Citations
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

1245
Citations
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

1188
Citations
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

Philip J. Barter;H. Bryan Brewer;M. John Chapman;Charles H. Hennekens

1092
Citations
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

Anatol Kontush;M. John Chapman

929
Citations
ESC/EAS Guidelines for the management of dyslipidaemias

Alberico L. Catapano;Željko Reiner;Guy De Backer;Ian Graham

914
Citations
Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

902
Citations
Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points - A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Børge G. Nordestgaard;Anne Langsted;Samia Mora;Genovefa Kolovou

769
Citations
Dysfunctional HDL and atherosclerotic cardiovascular disease

Robert S. Rosenson;H. Bryan Brewer;Benjamin J. Ansell;Philip Barter

722
Citations
Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes

Brian A. Ference;Jennifer G. Robinson;Robert D. Brook;Alberico L. Catapano

717
Citations
Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

705
Citations

Frequent Co-Authors

Alberico L. Catapano University of Milan

Stephen J. Nicholls Monash University

Marja-Riitta Taskinen University of Helsinki

Henry N. Ginsberg Columbia University

Lale Tokgozoglu Hacettepe University

Jan Borén University of Gothenburg

Børge G. Nordestgaard University of Copenhagen

Christie M. Ballantyne Baylor College of Medicine

Raimund Erbel University of Duisburg-Essen

Peter Libby Brigham and Women's Hospital

External Links

Personal website of M. John Chapman

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a career in medicine often begins with exploring accessible online degree options in healthcare. For those considering nursing, there are many cheap online nursing programs that provide flexible and budget-friendly pathways into the profession. These programs are ideal for students balancing work or family commitments.

Experienced nurses looking to advance into leadership or specialized roles can explore the cheapest dnp programs, which offer advanced clinical training at a more affordable cost. Additionally, registered nurses aiming to obtain their bachelor's degree can find what is the cheapest rn to bsn program online to help expand career opportunities and meet evolving healthcare standards.

For individuals with a non-nursing background seeking a fast path into advanced practice, there are direct entry msn programs for non-nurses online. These programs offer a streamlined route into nursing at the master’s level, catering to career changers and those eager to make an impact in healthcare.